Investigator Site 0010115 — Pittsburgh, Pennsylvania

Investigator Site 0010115 is a clinical research site located in Pittsburgh, Pennsylvania, United States 15222.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator Site 0010115 has participated in 1 clinical trials.

Therapeutic areas: Primary Immune Thrombocytopenia.

Sponsors: argenx.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 0010115?

Investigator Site 0010115 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 0010115 conducted?

Investigator Site 0010115 has 1 clinical trials on record. Their work covers Primary Immune Thrombocytopenia.

Is Investigator Site 0010115 accredited by Crixeo Health?

Investigator Site 0010115 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 0010115?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.